Dermatology Grand Rounds
Wednesday, September 17, 2014
Wednesday, Sep. 17th 2014 at 8am-12pm
676 North Saint Clair Street, Suite 1600 (16th Floor)
Presenting at 8:00am
The Development of Exosomes for Metastatic Melanoma
Presenting at 10:45am
Sarcoidosis: Systemic Symptoms, Workup, and Management
Misha A Rosenbach, MD
Assistant Professor of Dermatology and Internal Medicine
Perelman School of Medicine
University of Pennsylvania
Misha Rosenbach MD FAAD is an Assistant Professor of Dermatology and Internal Medicine at the Perelman School of Medicine at the University of Pennsylvania. He completed his undergraduate work at Princeton University, medical school at Cornell University, and then a combined IM/Derm residency at University of Pennsylvania where he served as chief resident. He stayed on as faculty and now is the Director of the Inpatient Consult Service, and serves a variety of educational roles including Associate Program Director of the Dermatology Residency Program, and core clinical faculty in the Department of Medicine, while directing the dermatology elective for the medical students. He is focused on complex medical dermatology, and runs an urgent care clinic, a sarcoidosis clinic, and sees inpatients and patients with complex autoimmune skin conditions or undiagnosed diseases; his research is focused primarily on sarcoidosis and granulomatous skin conditions.
Overall meeting objectives:
At the conclusion of this activity, participants should be able to:
1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Course Director: Amy S. Paller, MD, MS, Chair, Department of Dermatology
The course director Amy S. Paller, MD, MS serves as a consultant (with honoraria)for the following companies: AbbVie, Alwyn, Anacor Pharmaceuticals, Inc., Best Doctors, Celgene Corporation, Galderma Laboratories, L.P., GlaxoSmithKline, LEO Pharma US, Lundbeck, Novartis Pharmaceuticals Corp., Onset Dermatologics, Procter & Gamble Company, Promius Pharma, LLC., Scioderm, and Stiefel a GSK company.
Amy S. Paller, MD, MS serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Galderma Laboratories, LP, LEO Pharma US, and TopMD.
FSM’s listed CME Leadership and Staff have nothing to disclose: John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education, Genevieve Napier, CME Director, Jen Banys, Michelle Mallery, and Tristan Brown, CME Project Specialists.
Michael Plebanek has nothing to disclose.
C. Shad Thaxton, MD receives intellectual property as a consultant for AuraSense Therapeutics.
Misha A. Rosenbach, MD will be discussing a product which is has not been approved by the FDA. Dr. Rosenbach serves as a Principle Investigator for Centocor.
Sponsored by: Department of Dermatology
The next Grand Rounds will be held Wednesday, October 15, 2014
Dermatology Grand Rounds
Presenting at 8:00 am
Presenting at 10:45 am
Skin Cancer in Organ Transplant Recipients
Guest Speaker: Thomas Stasko, M.D.
Professor and Chair, Department of Dermatology
The University of Oklahoma Health Sciences Center